Stockscreener 앱 받기
165.35
0.20%
-0.33
Insulet Corp 주식(PODD)의 최신 뉴스
PODD SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of Insulet Corporation Investors - GlobeNewswire Inc.
Insulet Corp. stock outperforms competitors on strong trading day - MarketWatch
Insulet Corp (PODD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Insulet Corp (PODD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Insulet Market Sentiment - Benzinga España
Insulet Corp (PODD) Income Statement - TradingKey
PODD|Insulet Corp|Price:164.940|Chg%:+1.680 - TradingKey
Insulet Corp (PODD) Valuation: PE, PB & Fair Value Analysis - TradingKey
Insulet Corp (PODD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Insulet Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – PODD - GlobeNewswire Inc.
Insulet Corp Shs Unsponsored Brazilian Depositary Receipt Repr 0.03333333 Sh - TradingView
Insulet Corp (PODD) Cash Flow - TradingKey
Insulet Corp (PODD) Shares Surge 3.1% -- What GF Score of 81 Tel - GuruFocus
Insulet examines mental health toll of diabetes in partnership with meditation app Calm - Medical Marketing and Media
Insulet Corp (PODD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit - PR Newswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Insulet Corporation and Certain OfficersPODD - PR Newswire
Insulet Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Insulet Corporation (PODD) Stock Price, News, Quote & History - Yahoo! Finance Canada
Insulet's Q2 2026 Earnings: What to Expect - Yahoo Finance
Insulet Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Insulet Corporation Class Action Reminder – Robbins LLP - GlobeNewswire
Insulet stock trades steady as Omnipod growth supports long term diabetes opportunity - Ad-hoc-news.de
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Planet Fitness, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
PODD EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Insulet (PODD) Investors of Securities Class Action Lawsuit Deadline on August 31, 2026 - marketscreener.com
Bronstein, Gewirtz & Grossman LLC Urges Insulet Corporation - GlobeNewswire
Lost Money on Insulet Corporation (PODD)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - GlobeNewswire
PODD SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Insulet (PODD) Investors of Securities Class Action Lawsuit Deadline on August 31, 2026 - marketscreener.com
Robbins LLP Urges PODD Stockholders to Contact the Firm for Information About the Class Action Against Insulet Corporation - TMX Newsfile
PODD DEADLINE: The Gross Law Firm Reminds Insulet - GlobeNewswire
symbol__ Stock Quote Price and Forecast - CNN
Insulet stock trades near recent lows as Omnipod margins tighten after GLP-1 demand shift - Ad Hoc News
Insulet Corp (PODD) Stock Up 3.2% and Still Undervalued -- GF Sc - GuruFocus
Insulet Corporation (PODD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Barchart.com
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Insulet Corp (NASDAQ:PODD): A Quality Affordable Growth Stock With Strong Earnings Momentum - ChartMill
Lila Moss narrates a new sleep story for the diabetes community - Stock Titan
INVESTOR ALERT: Faruqi & Faruqi, LLP Reminds Insulet Investors of - The National Law Review
Insulet Corp. stock outperforms competitors despite losses on the day - MarketWatch
PODD Court News: Insulet Class Action Lawsuit Alleges Securities Fraud on behalf of Investors with Losses - PR Newswire
Insulet Corporation (PODD) Fell Along with Broad Medtech Sector - Yahoo Finance
Here's How Much You'd Have If You Invested $1000 in Insulet a Decade Ago - Yahoo Finance
Lobbying Update: $60,000 of INSULET CORPORATION lobbying was just disclosed - Quiver Quantitative
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Insulet - GlobeNewswire
PODD Shareholder Alert: Insulet Corporation Securities - GlobeNewswire
Stifel cuts Insulet stock price target on valuation, keeps buy rating - Investing.com
Insulet stock reflects steady diabetes tech demand as investors watch U.S. growth - AD HOC NEWS
Insulet (PODD) Stock Still Trades At A Premium As Shares Fell 47% - Yahoo Finance
Insulet (PODD) Launches Omnipod 5 In Spain, Is The Stock Cheap? - Yahoo Finance
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 31, 2026 in Insulet Corporation LawsuitPODD - Morningstar
PODD Shareholder Alert: Insulet Corporation Securities Class Action LawsuitInvestors With Losses May Contact Levi & Korsinsky - Business Wire
Insulet focuses on diabetes technology growth. Business model supports recurring revenue - Ad-hoc-news.de
1.04%
11.95%
자본화:
|
볼륨(24시간):